<DOC>
	<DOCNO>NCT00644319</DOCNO>
	<brief_summary>RATIONALE : Morphine ibuprofen help lessen pain caused pleurodesis . It yet know whether one drug effective lessen pleurodesis-related pain whether size chest drain tube affect pain . PURPOSE : This randomized clinical trial study ibuprofen see well work compare morphine treat pain patient undergoing pleurodesis malignant pleural effusion .</brief_summary>
	<brief_title>Ibuprofen Morphine Treating Pain Patients Undergoing Pleurodesis Malignant Pleural Effusion</brief_title>
	<detailed_description>OBJECTIVES : Primary - To evaluate efficacy non-steroidal base regimen comprise ibuprofen decrease post-pleurodesis pain compare opiate-based regimen comprise morphine sulfate patient malignant pleural effusion . - To evaluate whether chest drain size influence amount post-pleurodesis pain . OUTLINE : This multicenter study . Patients stratify accord histological tissue type ( mesothelioma v non-mesothelioma ) thoracoscopic procedure . Patients randomize 1 4 treatment arm . - Arm I : Patients undergo pleurodesis placement large bore chest drain ( 24F ) day 0 receive oral ibuprofen 3 time daily 3 day . The chest tube remove day 3 . - Arm II : Patients undergo pleurodesis placement small bore chest drain ( 12F ) day 0 receive oral ibuprofen 3 time daily 3 day . The chest tube remove day 3 . - Arm III : Patients undergo pleurodesis placement large bore chest drain ( 24F ) day 0 receive oral morphine sulfate 4 time daily 3 day . The chest tube remove day 3 . - Arm IV : Patients undergo pleurodesis placement small bore chest drain ( 12F ) day 0 receive oral morphine sulfate 4 time daily 3 day . The chest tube remove day 3 . All patient receive regular background analgesia comprise paracetamol 4 time daily day 0-3 . Patients adequately treat regimen may also receive rescue analgesia comprise morphine sulfate IV day 0-3 . After completion study treatment , patient follow 1 , 3 , 6 month , periodically thereafter .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis malignant pleural effusion require pleurodesis confirm 1 following : Histologically proven pleural malignancy Typical feature pleural malignancy see direct vision thoracoscopy Pleural effusion context histologically proven cancer elsewhere No primary lymphoma small cell lung carcinoma All patient undergo thoracoscopy suspect malignant pleural effusion eligible PATIENT CHARACTERISTICS : Life expectancy &gt; 1 month Not pregnant nursing No history GI bleeding untreated peptic ulceration No known sensitivity nonsteroidal antiinflammatory drug ( NSAIDs ) , opiates , paracetamol No hypercapnic respiratory failure No known intravenous drug abuse No severe renal liver disease No known bleed diathesis Able give inform consent PRIOR CONCURRENT THERAPY : More 2 week since prior concurrent corticosteroid therapy No concurrent warfarin therapy No concurrent analgesic Analgesics use breakthrough regimen allow trial entry tube withdrawal day 3 postpleurodesis ( i.e. , regular paracetamol , assign study analgesia , breakthrough medication , include opiate slow release patch ) No concurrent enrollment another clinical study Patients may participate trial immediately completion current trial , exclude involve pleural procedure analgesia trial patient must wait least 3 month completion current trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>malignant pleural effusion</keyword>
</DOC>